CollPlant Biotechnologies Investor Relations Material
Latest events
Q4 2024
CollPlant Biotechnologies
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CollPlant Biotechnologies Ltd
Access all reports
CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine company focused on developing and commercializing products for tissue regeneration and organ manufacturing. The company utilizes its proprietary plant-based recombinant human collagen (rhCollagen) technology to create products that address unmet medical needs in various sectors, including wound care, orthopedics, and 3D bioprinting of tissues and organs. Key offerings include bioinks for 3D printing, wound care products, and orthobiologics. The company collaborates with industry partners to advance its innovative solutions and expand its market presence. The company is headquartered in Rehovot, Israel, and its shares are listed on the NASDAQ.
Latest articles
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
Ticker symbol
CLGN
Country
🇺🇸 United States